Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Fu

Showing results (251-260 of 267) with videos related to

Pageof 27
Sort By:
Environment International|June 14, 2011
Determination of polybrominated diphenyl ethers in human semenPeng-Yan Liu, Ya-Xian Zhao, Yi-Yang Zhu, et al.
Medicine|February 3, 2017
Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: A nationwide osteoporosis surveyShan-Fu Yu, Jia-Feng Chen, Yin-Chou Chen, et al.
Molecular Oncology|December 14, 2011
CRABP-II methylation: a critical determinant of retinoic acid resistance of medulloblastoma cellsYuan-Shan Fu, Qian Wang, Jing-Xin Ma, et al.
Bone Marrow Transplantation|August 20, 2025
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphomaYetian Dong, Tingting Yang, Mengyu Zhao, et al.
Haematologica|June 27, 2012
Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignanciesHaowen Xiao, Yi Luo, Xiaoyu Lai, et al.
Stem Cell Research & Therapy|June 20, 2021
Enhanced HSC-like cell generation from mouse pluripotent stem cells in a 3D induction system cocultured with stromal cellsWei Shan, Qin Yu, Yan Long, et al.
Plos One|August 4, 2021
Risk factor analysis of fragility fractures in rheumatoid arthritis: A 3-year longitudinal, real-world, observational, cohort studyPo-Heng Lin, Shan-Fu Yu, Jia-Feng Chen, et al.
The Lancet. Haematology|February 1, 2023
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trialMingming Zhang, Guoqing Wei, Linghui Zhou, et al.
Current Research in Translational Medicine|July 5, 2020
CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challengesYongxian Hu, Elaine Tan Su Yin, Yingying Yang, et al.
Bone Marrow Transplantation|December 13, 2025
Predictive values of baseline <sup>18</sup>F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapyPingnan Xiao, Xin Zhao, Linqin Wang, et al.
Pageof 27

Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Environment International|June 14, 2011
Determination of polybrominated diphenyl ethers in human semenPeng-Yan Liu, Ya-Xian Zhao, Yi-Yang Zhu, et al.
Medicine|February 3, 2017
Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: A nationwide osteoporosis surveyShan-Fu Yu, Jia-Feng Chen, Yin-Chou Chen, et al.
Molecular Oncology|December 14, 2011
CRABP-II methylation: a critical determinant of retinoic acid resistance of medulloblastoma cellsYuan-Shan Fu, Qian Wang, Jing-Xin Ma, et al.
Bone Marrow Transplantation|August 20, 2025
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphomaYetian Dong, Tingting Yang, Mengyu Zhao, et al.
Haematologica|June 27, 2012
Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignanciesHaowen Xiao, Yi Luo, Xiaoyu Lai, et al.
Stem Cell Research & Therapy|June 20, 2021
Enhanced HSC-like cell generation from mouse pluripotent stem cells in a 3D induction system cocultured with stromal cellsWei Shan, Qin Yu, Yan Long, et al.
Plos One|August 4, 2021
Risk factor analysis of fragility fractures in rheumatoid arthritis: A 3-year longitudinal, real-world, observational, cohort studyPo-Heng Lin, Shan-Fu Yu, Jia-Feng Chen, et al.
The Lancet. Haematology|February 1, 2023
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trialMingming Zhang, Guoqing Wei, Linghui Zhou, et al.
Current Research in Translational Medicine|July 5, 2020
CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challengesYongxian Hu, Elaine Tan Su Yin, Yingying Yang, et al.
Bone Marrow Transplantation|December 13, 2025
Predictive values of baseline <sup>18</sup>F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapyPingnan Xiao, Xin Zhao, Linqin Wang, et al.
Pageof 27